Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack.

Skarpengland T, Skjelland M, Kong XY, Skagen K, Holm S, Otterdal K, Dahl CP, Krohg-Sørensen K, Sagen EL, Bjerkeli V, Aamodt AH, Abbas A, Gregersen I, Aukrust P, Halvorsen B, Dahl TB.

J Am Heart Assoc. 2018 Jan 12;7(2). pii: e006479. doi: 10.1161/JAHA.117.006479.

2.

18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques.

Johnsrud K, Skagen K, Seierstad T, Skjelland M, Russell D, Revheim ME.

J Nucl Cardiol. 2017 Dec 5. doi: 10.1007/s12350-017-1121-7. [Epub ahead of print]

PMID:
29209949
3.

Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation.

Gregersen I, Sandanger Ø, Askevold ET, Sagen EL, Yang K, Holm S, Pedersen TM, Skjelland M, Krohg-Sørensen K, Hansen TV, Dahl TB, Otterdal K, Espevik T, Aukrust P, Yndestad A, Halvorsen B.

PLoS One. 2017 Nov 27;12(11):e0188387. doi: 10.1371/journal.pone.0188387. eCollection 2017.

4.

Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation.

Bakke SS, Aune MH, Niyonzima N, Pilely K, Ryan L, Skjelland M, Garred P, Aukrust P, Halvorsen B, Latz E, Damås JK, Mollnes TE, Espevik T.

J Immunol. 2017 Oct 15;199(8):2910-2920. doi: 10.4049/jimmunol.1700302. Epub 2017 Aug 30.

PMID:
28855312
5.

Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages.

Espada S, Stavik B, Holm S, Sagen EL, Bjerkeli V, Skjelland M, Dahl TB, Espevik T, Kanse S, Sandset PM, Skretting G, Halvorsen B.

Biochem Biophys Res Commun. 2017 Sep 16;491(2):442-448. doi: 10.1016/j.bbrc.2017.07.070. Epub 2017 Jul 13.

PMID:
28712870
6.

Increased expression of TFPI in human carotid stenosis.

Stavik B, Holm S, Espada S, Iversen N, Sporsheim B, Bjerkeli V, Dahl TB, Sandset PM, Skjelland M, Espevik T, Skretting G, Halvorsen B.

Thromb Res. 2017 Jul;155:31-37. doi: 10.1016/j.thromres.2017.04.024. Epub 2017 Apr 28.

PMID:
28482260
7.

Increased levels of legumain in plasma and plaques from patients with carotid atherosclerosis.

Lunde NN, Holm S, Dahl TB, Elyouncha I, Sporsheim B, Gregersen I, Abbas A, Skjelland M, Espevik T, Solberg R, Johansen HT, Halvorsen B.

Atherosclerosis. 2017 Feb;257:216-223. doi: 10.1016/j.atherosclerosis.2016.11.026. Epub 2016 Nov 28.

PMID:
27940038
8.

Unstable carotid artery plaque: new insights and controversies in diagnostics and treatment.

Skagen K, Skjelland M, Zamani M, Russell D.

Croat Med J. 2016 Aug 31;57(4):311-20. Review.

9.

Enhanced base excision repair capacity in carotid atherosclerosis may protect nuclear DNA but not mitochondrial DNA.

Skarpengland T, Dahl TB, Skjelland M, Scheffler K, de Sousa MML, Gregersen I, Kuśnierczyk A, Sharma A, Slupphaug G, Eide L, Segers FM, Skagen KR, Dahl CP, Russell D, Folkersen L, Krohg-Sørensen K, Holm S, Bjørås M, Aukrust P, Halvorsen B.

Free Radic Biol Med. 2016 Aug;97:386-397. doi: 10.1016/j.freeradbiomed.2016.07.001. Epub 2016 Jul 2.

PMID:
27381496
10.

Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice.

Skarpengland T, Holm S, Scheffler K, Gregersen I, Dahl TB, Suganthan R, Segers FM, Østlie I, Otten JJ, Luna L, Ketelhuth DF, Lundberg AM, Neurauter CG, Hildrestrand G, Skjelland M, Bjørndal B, Svardal AM, Iversen PO, Hedin U, Nygård S, Olstad OK, Krohg-Sørensen K, Slupphaug G, Eide L, Kuśnierczyk A, Folkersen L, Ueland T, Berge RK, Hansson GK, Biessen EA, Halvorsen B, Bjørås M, Aukrust P.

Sci Rep. 2016 Jun 22;6:28337. doi: 10.1038/srep28337.

11.

Blood Pressure Lowering Treatment in Patients with Carotid Artery Stenosis.

Jusufovic M, Sandset EC, Skagen K, Skjelland M.

Curr Hypertens Rev. 2016;12(2):148-55. Review.

PMID:
27292176
12.

Semiautomated Magnetic Resonance Imaging Assessment of Carotid Plaque Lipid Content.

Skagen K, Evensen K, Scott H, Krohg-Sørensen K, Vatnehol SA, Hol PK, Skjelland M, Russell D.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):2004-10. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.043. Epub 2016 May 24.

PMID:
27234919
13.

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis.

Paramel Varghese G, Folkersen L, Strawbridge RJ, Halvorsen B, Yndestad A, Ranheim T, Krohg-Sørensen K, Skjelland M, Espevik T, Aukrust P, Lengquist M, Hedin U, Jansson JH, Fransén K, Hansson GK, Eriksson P, Sirsjö A.

J Am Heart Assoc. 2016 May 20;5(5). pii: e003031. doi: 10.1161/JAHA.115.003031.

14.

Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.

Zimmer S, Grebe A, Bakke SS, Bode N, Halvorsen B, Ulas T, Skjelland M, De Nardo D, Labzin LI, Kerksiek A, Hempel C, Heneka MT, Hawxhurst V, Fitzgerald ML, Trebicka J, Björkhem I, Gustafsson JÅ, Westerterp M, Tall AR, Wright SD, Espevik T, Schultze JL, Nickenig G, Lütjohann D, Latz E.

Sci Transl Med. 2016 Apr 6;8(333):333ra50. doi: 10.1126/scitranslmed.aad6100.

15.

The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.

Skagen K, Trøseid M, Ueland T, Holm S, Abbas A, Gregersen I, Kummen M, Bjerkeli V, Reier-Nilsen F, Russell D, Svardal A, Karlsen TH, Aukrust P, Berge RK, Hov JE, Halvorsen B, Skjelland M.

Atherosclerosis. 2016 Apr;247:64-9. doi: 10.1016/j.atherosclerosis.2016.01.033. Epub 2016 Feb 5.

PMID:
26868510
16.

Cerebral venous thrombectomy.

Jusufovic M, Gjertsen Ø, Khalid F, Tennøe B, Skjelland M.

Tidsskr Nor Laegeforen. 2015 Oct 20;135(19):1752. doi: 10.4045/tidsskr.15.0538. eCollection 2015 Oct 20. English, Norwegian. No abstract available.

17.

Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages.

Halvorsen B, Espeland MZ, Andersen GØ, Yndestad A, Sagen EL, Rashidi A, Knudsen EC, Skjelland M, Skagen KR, Krohg-Sørensen K, Holm S, Ritschel V, Holven KB, Biessen EA, Aukrust P, Dahl TB.

Atherosclerosis. 2015 Nov;243(1):204-10. doi: 10.1016/j.atherosclerosis.2015.09.010. Epub 2015 Sep 8.

18.

Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.

Skagen K, Skjelland M, Russell D, Jacobsen EA.

J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1532-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.020. Epub 2015 Apr 23.

PMID:
25922156
19.

[Fluctuating carotid tumor].

Skagen K, Marthinsen PB, Skjelland M, Lund CG.

Tidsskr Nor Laegeforen. 2015 Feb 24;135(4):337. doi: 10.4045/tidsskr.14.0898. eCollection 2015 Feb 24. Norwegian. No abstract available.

20.

Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis.

Abbas A, Gregersen I, Holm S, Daissormont I, Bjerkeli V, Krohg-Sørensen K, Skagen KR, Dahl TB, Russell D, Almås T, Bundgaard D, Alteheld LH, Rashidi A, Dahl CP, Michelsen AE, Biessen EA, Aukrust P, Halvorsen B, Skjelland M.

Stroke. 2015 Mar;46(3):793-9. doi: 10.1161/STROKEAHA.114.006516. Epub 2015 Feb 3.

21.

Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients.

Skagen K, Johnsrud K, Evensen K, Scott H, Krohg-Sørensen K, Reier-Nilsen F, Revheim ME, Fjeld JG, Skjelland M, Russell D.

Int J Stroke. 2015 Jul;10(5):730-6. doi: 10.1111/ijs.12430. Epub 2015 Jan 15.

PMID:
25588553
22.

Mechanical embolectomy in cerebral infarction.

Jusufovic M, Nome T, Skjelland M, Jacobsen EA.

Tidsskr Nor Laegeforen. 2014 Oct 28;134(20):1961. doi: 10.4045/tidsskr.14.0734. eCollection 2014 Oct 28. English, Norwegian. No abstract available.

23.

Deep brain stimulation in essential tremor.

Jusufovic M, Konglund AE, Beyer MK, Dietrichs E, Skjelland M.

Tidsskr Nor Laegeforen. 2014 Sep 30;134(18):1757. doi: 10.4045/tidsskr.14.0376. eCollection 2014 Sep 30. English, Norwegian. No abstract available.

24.

Long-term follow-up of thalamic deep brain stimulation for essential tremor - patient satisfaction and mortality.

Børretzen MN, Bjerknes S, Sæhle T, Skjelland M, Skogseid IM, Toft M, Dietrichs E.

BMC Neurol. 2014 Jun 5;14:120. doi: 10.1186/1471-2377-14-120.

25.

CXCR4 blockade induces atherosclerosis by affecting neutrophil function.

Bot I, Daissormont IT, Zernecke A, van Puijvelde GH, Kramp B, de Jager SC, Sluimer JC, Manca M, Hérias V, Westra MM, Bot M, van Santbrink PJ, van Berkel TJ, Su L, Skjelland M, Gullestad L, Kuiper J, Halvorsen B, Aukrust P, Koenen RR, Weber C, Biessen EA.

J Mol Cell Cardiol. 2014 Sep;74:44-52. doi: 10.1016/j.yjmcc.2014.04.021. Epub 2014 May 8.

26.

Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.

Halvorsen B, Smedbakken LM, Michelsen AE, Skjelland M, Bjerkeli V, Sagen EL, Taskén K, Bendz B, Gullestad L, Holm S, Biessen EA, Aukrust P.

Atherosclerosis. 2014 Jun;234(2):352-9. doi: 10.1016/j.atherosclerosis.2014.03.021. Epub 2014 Mar 31.

PMID:
24732574
27.

Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.

Halvorsen B, Dahl TB, Smedbakken LM, Singh A, Michelsen AE, Skjelland M, Krohg-Sørensen K, Russell D, Höpken UE, Lipp M, Damås JK, Holm S, Yndestad A, Biessen EA, Aukrust P.

Cardiovasc Res. 2014 Apr 1;102(1):148-56. doi: 10.1093/cvr/cvu036. Epub 2014 Feb 11.

PMID:
24518141
28.

Ischaemic stroke with patent foramen ovale.

Jusufovic M, Thomassen L, Skjelland M.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):180-4. doi: 10.4045/tidsskr.13.0038. Review. English, Norwegian.

29.

Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis.

Abbas A, Aukrust P, Russell D, Krohg-Sørensen K, Almås T, Bundgaard D, Bjerkeli V, Sagen EL, Michelsen AE, Dahl TB, Holm S, Ueland T, Skjelland M, Halvorsen B.

PLoS One. 2014 Jan 6;9(1):e84935. doi: 10.1371/journal.pone.0084935. eCollection 2014.

30.

Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis.

Gregersen I, Skjelland M, Holm S, Holven KB, Krogh-Sørensen K, Russell D, Askevold ET, Dahl CP, Ørn S, Gullestad L, Mollnes TE, Ueland T, Aukrust P, Halvorsen B.

PLoS One. 2013 Aug 30;8(8):e72769. doi: 10.1371/journal.pone.0072769. eCollection 2013.

31.

Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization.

Smedbakken LM, Halvorsen B, Daissormont I, Ranheim T, Michelsen AE, Skjelland M, Sagen EL, Folkersen L, Krohg-Sørensen K, Russell D, Holm S, Ueland T, Fevang B, Hedin U, Yndestad A, Gullestad L, Hansson GK, Biessen EA, Aukrust P.

Atherosclerosis. 2012 Sep;224(1):266-73. doi: 10.1016/j.atherosclerosis.2012.06.071. Epub 2012 Jul 20.

PMID:
22840692
32.

High levels of S100A12 are associated with recent plaque symptomatology in patients with carotid atherosclerosis.

Abbas A, Aukrust P, Dahl TB, Bjerkeli V, Sagen EB, Michelsen A, Russell D, Krohg-Sørensen K, Holm S, Skjelland M, Halvorsen B.

Stroke. 2012 May;43(5):1347-53. doi: 10.1161/STROKEAHA.111.642256. Epub 2012 Mar 1. Erratum in: Stroke. 2013 Jul;44(7):e82. Sørensen, Kirsten Krohg [corrected to Krohg-Sørensen, Kirsten].

33.

Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke.

Holm S, Ueland T, Dahl TB, Michelsen AE, Skjelland M, Russell D, Nymo SH, Krohg-Sørensen K, Clausen OP, Atar D, Januzzi JL, Aukrust P, Jensen JK, Halvorsen B.

PLoS One. 2011;6(12):e28785. doi: 10.1371/journal.pone.0028785. Epub 2011 Dec 9.

34.

Long-term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation.

Toft M, Lilleeng B, Ramm-Pettersen J, Skogseid IM, Gundersen V, Gerdts R, Pedersen L, Skjelland M, Røste GK, Dietrichs E.

Mov Disord. 2011 Aug 15;26(10):1931-4. doi: 10.1002/mds.23817. Epub 2011 Jun 8.

PMID:
21656853
35.

Activated platelets and atherosclerosis.

Aukrust P, Halvorsen B, Ueland T, Michelsen AE, Skjelland M, Gullestad L, Yndestad A, Otterdal K.

Expert Rev Cardiovasc Ther. 2010 Sep;8(9):1297-307. doi: 10.1586/erc.10.92. Review.

PMID:
20828352
36.

Increased YKL-40 expression in patients with carotid atherosclerosis.

Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sørensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B.

Atherosclerosis. 2010 Aug;211(2):589-95. doi: 10.1016/j.atherosclerosis.2010.02.035. Epub 2010 Mar 4.

PMID:
20347092
37.

Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation.

Breland UM, Michelsen AE, Skjelland M, Folkersen L, Krohg-Sørensen K, Russell D, Ueland T, Yndestad A, Paulsson-Berne G, Damås JK, Oie E, Hansson GK, Halvorsen B, Aukrust P.

Cardiovasc Res. 2010 May 1;86(2):265-73. doi: 10.1093/cvr/cvq044. Epub 2010 Feb 5.

PMID:
20139115
38.

[Carotis stenosis-open surgery and endovascular treatment].

Krohg-Sørensen K, Lingaas PS, Bakke SJ, Skjelland M.

Tidsskr Nor Laegeforen. 2009 Nov 5;129(21):2244-7. doi: 10.4045/tidsskr.09.0166. Norwegian.

39.

Atherosclerotic plaque stability--what determines the fate of a plaque?

Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, Øie E, Aukrust P.

Prog Cardiovasc Dis. 2008 Nov-Dec;51(3):183-94. doi: 10.1016/j.pcad.2008.09.001. Review.

PMID:
19026853
40.

Cerebral microemboli and brain injury during carotid artery endarterectomy and stenting.

Skjelland M, Krohg-Sørensen K, Tennøe B, Bakke SJ, Brucher R, Russell D.

Stroke. 2009 Jan;40(1):230-4. doi: 10.1161/STROKEAHA.107.513341. Epub 2008 Oct 16.

41.

Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability.

Handberg A, Skjelland M, Michelsen AE, Sagen EL, Krohg-Sørensen K, Russell D, Dahl A, Ueland T, Oie E, Aukrust P, Halvorsen B.

Stroke. 2008 Nov;39(11):3092-5. doi: 10.1161/STROKEAHA.108.517128. Epub 2008 Aug 21.

42.

Solid cerebral microemboli and cerebrovascular symptoms in patients with prosthetic heart valves.

Skjelland M, Michelsen A, Brosstad F, Svennevig JL, Brucher R, Russell D.

Stroke. 2008 Apr;39(4):1159-64. doi: 10.1161/STROKEAHA.107.493031. Epub 2008 Feb 21.

43.

Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity.

Skjelland M, Michelsen AE, Krohg-Sørensen K, Tennøe B, Dahl A, Bakke S, Brosstad F, Damås JK, Russell D, Halvorsen B, Aukrust P.

Atherosclerosis. 2007 Dec;195(2):e142-6. Epub 2007 Jun 12.

PMID:
17568588
44.

Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.

Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B.

Circulation. 2007 Feb 27;115(8):972-80. Epub 2007 Feb 5.

45.

Cerebral microembolization during off-pump coronary artery bypass surgery with the Symmetry aortic connector device.

Skjelland M, Bergsland J, Lundblad R, Lingaas PS, Rein KA, Halvorsen S, Svennevig JL, Fosse E, Brucher R, Russell D.

J Thorac Cardiovasc Surg. 2005 Dec;130(6):1581-5.

46.

[Treatment of writer's cramp with botulinum toxin].

Amthor KF, Skjelland M, Heier MS.

Tidsskr Nor Laegeforen. 1994 Jun 20;114(16):1830-1. Norwegian.

PMID:
8079300

Supplemental Content

Loading ...
Support Center